RLYB 8-K 2026-09-09

Rallybio Corp (RLYB) 8-K dated 2026-09-09 — accession 0001193125-26-386511. This URL is the filing, not the RLYB hub.

Rallybio Corp (RLYB) is a biotechnology company listed on US.

Rallybio Corp filed a 8-K on 2026-09-09. Accession 0001193125-26-386511.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.

Not investment advice. The RLYB SEC hub lists recent forms. The stock page is the research view.